Vicore Pharma Holding AB (publ) has appointed the Nomination Committee for the 2023 Annual General Meeting. The three large shareholders as of August 31, 2022 have been offered to appoint a member to the Nomination Committee each, in accordance with the decision taken at the Annual General Meeting on May 11, 2021. The Nomination Committee consists of Staffan Lindstrand, appointed by HealthCap VII L.P., Jan Särlvik, appointed by the Fourth Swedish National Pension Fund and Ivo Staijen appointed by HBM Healthcare Investments (Cayman) Ltd. Vicore's chairman, Jacob Gunterberg, is also a member and acts as the convener of the Nomination Committee.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
18.64 SEK | -1.58% | -5.48% | +31.45% |
May. 07 | Vicore Pharma Holding AB Announces Board Appointments | CI |
May. 03 | Vicore Pharma Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.45% | 198M | |
+9.37% | 114B | |
+13.61% | 107B | |
-9.50% | 22.22B | |
-1.60% | 21.28B | |
-4.55% | 18.8B | |
-5.62% | 17.51B | |
-39.93% | 17.17B | |
+7.00% | 14.14B | |
+34.62% | 12.2B |
- Stock Market
- Equities
- VICO Stock
- News Vicore Pharma Holding AB
- Vicore Pharma Holding AB Announces the Appointment of Nomination Committee